Parag Saxena 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-22 4:30 pm Purchase | 2025-12-18 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 313,400 5.200% | 410 (+0.13%) | Filing |
| 2025-09-24 4:30 pm Unchanged | 2025-09-22 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 312,990 6.200% | 0 (Unchanged) | Filing |
| 2025-07-01 6:40 pm Sale | 2025-06-27 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 312,990 8.700% | -455 (-0.15%) | Filing |
| 2025-01-31 9:31 pm Purchase | 2024-12-18 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 313,445 12.400% | 865 (+0.28%) | Filing |
| 2024-08-23 4:07 pm Purchase | 2024-08-22 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 312,580 16.900% | 312,580 (New Position) | Filing |